Ann Thorac Surg 2009;88:1792. doi:10.1016/j.athoracsur.2009.09.011
© 2009 The Society of Thoracic Surgeons
Original Articles: Adult Cardiac
Invited Commentary
Rohinton J. Morris, MD
Division of Cardiothoracic Surgery, University of Pennsylvania Health Systems, PHI Bldg, 51 N 39th St, Suite 2D, Philadelphia, PA 19104
(Email: rohinton.morris@uphs.upenn.edu).
| The first 20% of the full text of this article appears below. |
Management of acute myocardial infarction, characterized by ST-segment elevation (STEMI) remains a vexing problem. With the advent of routine and early antiplatelet and antithrombotic drug therapy (clopidogrel, and so forth), prompt institution of intra-aortic balloon pump (IABP) support and aggressive percutaneous coronary intervention have changed the landscape of treatment. Although surgical revascularization remains a viable option, many factors have precluded widespread, early referral to the cardiac surgeon. Hagl and colleagues [1] report their . . . [Full Text of this Article]
Related Article
-
Acute Treatment of ST-Segment-Elevation Myocardial Infarction: Is There a Role for the Cardiac Surgeon?
- Christian Hagl, Nawid Khaladj, Sven Peterss, Andreas Martens, Ingo Kutschka, Heidi Goerler, Malakh Shrestha, and Axel Haverich
Ann. Thorac. Surg. 2009 88: 1786-1792.
[Abstract]
[Full Text]
[PDF]
Copyright © 2009 by The Society of Thoracic Surgeons.